79 filings
Page 2 of 4
CORRESP
i1lkrsj7 3h6nyms5y4
9 Nov 23
Correspondence with SEC
12:00am
UPLOAD
q9mhwfb9g8mjaon2meu
7 Nov 23
Letter from SEC
12:00am
S-3
ux6vd4 2ju8cnqnq
3 Nov 23
Shelf registration
5:23pm
8-K
ak97m9 lh42pewk6
3 Nov 23
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:06pm
8-K
g5j4uxsqp
7 Aug 23
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:04pm
8-K
yqafb 02h
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
56sl9r4f4to
17 May 23
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
7:09am
DEFA14A
cjnxyt0r7x6i 10rbcl
11 May 23
Additional proxy soliciting materials
8:09am
8-K
oeov1f
11 May 23
Departure of Directors or Certain Officers
8:08am
8-K
2dmkx0d7a8y0gx
11 May 23
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
8:05am
ARS
hmri4qoauzzbr2
28 Apr 23
Annual report to shareholders
8:51am
DEFA14A
8ioi 0cs1mvee
28 Apr 23
Additional proxy soliciting materials
8:38am
DEF 14A
bbuwfq
28 Apr 23
Definitive proxy
8:34am
8-K/A
smnmad kk
10 Mar 23
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:00am
S-8
kozrzmt3qg6zvm0k
9 Mar 23
Registration of securities for employees
4:17pm
10-K
dacai 6qxnpmjj
9 Mar 23
Annual report
3:02pm
8-K
bet5j
9 Mar 23
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:26am